Chlamydia trachomatis infection in women: A need for universal screening in high prevalence populations?

American Journal of Epidemiology

Volumn 135, Issue 1, 1992, Pages 41-47

  Weinstock, Hillard S ^a   Bolan, Gail A ^b   Kohn, Robert ^b   Balladares, Carlos ^b   Back, Arthur ^b   Oliva, Geraldine ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH   (United States)

Author keywords

Chlamydia; Risk factors; Sensitivity and specificity (epidemiology); Sexually transmitted diseases

Indexed keywords

ADOLESCENT; ADULT; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONFERENCE PAPER; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR; SEXUAL TRANSMISSION;

AGE DISTRIBUTION; AGE FACTORS; AMERICAS; BARRIER METHODS; BEHAVIOR; BIOLOGY; CALIFORNIA; CERVIX--CHANGES; CHLAMYDIA; CONTRACEPTION; CONTRACEPTIVE METHODS; CONTRACEPTIVE USAGE; DATA ANALYSIS; DEMOGRAPHIC FACTORS; DEVELOPED COUNTRIES; DISEASES; EXAMINATIONS AND DIAGNOSES; FAMILY PLANNING; GENITALIA; GENITALIA, FEMALE; INFECTIONS; LABORATORY EXAMINATIONS AND DIAGNOSES; MARITAL STATUS; NORTH AMERICA; NORTHERN AMERICA; NUPTIALITY; PHYSIOLOGY; POPULATION; POPULATION AT RISK; POPULATION CHARACTERISTICS; REPRODUCTIVE TRACT INFECTIONS; RESEARCH METHODOLOGY; RISK FACTORS; SCREENING--STANDARDS; SEX BEHAVIOR; SEXUALLY TRANSMITTED DISEASES; STATISTICAL REGRESSION; UNITED STATES; UROGENITAL SYSTEM; UTERUS;

ADOLESCENT; ADULT; AMBULATORY CARE FACILITIES; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FAMILY PLANNING; FEMALE; GENITAL DISEASES, FEMALE; HUMAN; MIDDLE AGE; PREDICTIVE VALUE OF TESTS; PREVALENCE; RISK FACTORS; SAN FRANCISCO; SENSITIVITY AND SPECIFICITY; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0026569352     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a116200     Document Type: Article

References (22)

1. Chlamydia trachomatis infections: policy guidelines for prevention and control. MMWR 1985; 34(suppl):53s-74s.
2. Thompson SE, Washington AE. Epidemiology of sexually transmitted Chlamydia trachomatis infections. Epidemiol Rev 1983;5:96-123.
3. Washington AE, Johnson RE, Sanders LL Jr. Chlamydia trachomatis infections in the United States: What are they costing us? JAMA 1987;257: 2070-2.
4. Schachter J, Stoner E, Moncada J. Screening for chlamydial infections in women attending family planning clinics. West J Med 1983;138:375-9.
5. Jones MF, Smith TF, Houglum AJ, et al. Detection of Chlamydia trachomatis in genital specimens by the Chlamydiazyme test. J Gin Microbiol 1984; 20:465-7.
6. Tam MR, Stamm WE, Handsfield HH, et al. Culture-independent diagnosis of Chlamydia trachomatis using monoclonal antibodies. N Engl J Med 1984;310:1146-50.
7. Kent GP, Harrison HR, Berman SM, et al. Screening for Chlamydia trachomatis infection in a sexually transmitted disease clinic: comparison of diagnostic tests with clinical and historical risk factors. Sex Transm Dis 1988;15:51-7.
8. Magder LS, Harrison HR, Ehret JM, et al. Factors related to genital Chlamydia trachomatis and its diagnosis by culture in a sexually transmitted disease clinic. Am J Epidemiol 1988;128:298-308.
9. Handsfield HH, Jasman LL, Roberts PL, et al. Criteria for selective screening for Chlamydia trachomatis infection in women attending family planning clinics. JAMA 1986;255:43-7.
10. Eagar RM, Beach RK, Davidson AJ. Epidemiologic and clinical factors of Chlamydia trachomatis in black, Hispanic, and white female adolescents. West J Med 1985;143:37-41.
11. McCormack WM, Rosner B, McComb DE, et al. Infection with Chlamydia trachomatis in female college students. Am J Epidemiol 1985; 121:107- 15.
12. Glenney KF, Glassman DM, Cox SW, et al. The prevalence of positive test results for Chlamydia trachomatis by direct smear for fluorescent antibodies in a south Texas family planning population. J Reprod Med 1988;33:457-62.
13. SAS Institute, Inc. SUGI supplemental library user's guide. Cary, NC: SAS Institute, Inc., 1986.
14. Washington AE, Gove S, Schachter J, et al. Oral contraceptives, Chlamydia trachomatis infection and pelvic inflammatory disease. JAMA 1985;253: 2246-50.
15. Addiss DG, Vaughn ML, Golubjatnikov R, et al. Chlamydia trachomatis infection in women attending urban midwestem family planning and community health clinics: risk factors, selective screening, and evaluation of nonculture techniques. Sex Transm Dis 1990;17:138-46.
16. Schachter J. Why we need a program for the control of Chlamydia trachomatis. N Engl J Med 1989; 320:802-3.
17. Trachtenberg A, Washington AE, Halldorson S. A cost-based decision analysis for Chlamydia screening in California family planning clinics. Obstet Gynecol 1988;71:101-8.
18. Phillips RS, Aronson MD, Taylor WC, et al. Should tests for Chlamydia trachomatis cervical infection be done during routine gynecologic visits? An analysis of the costs of alternative strategies. Ann Intern Med 1987;107:188-94.
19. Nettleman MD, Jones RB. Cost-efTectiveness of screening women at moderate risk for genital infections caused by Chlamydia trachomatis. JAMA 1988;260:207-13.
20. Phillips RS, Hanf FPA, Kauffman RS, et al. Use of a direct fluorescent antibody test for detecting Chlamydia trachomatis cervical infection in women seeking routine gynecologic care. J Infect Dis 1987; 156:575-81.
21. Moncada J, Schachter J, Shipp M, et al. Cytobrush in collection of cervical specimens for detection of Chlamydia trachomatis. J Gin Microbiol 1989;27: 1863-6.
22. Stamm WE. Diagnosis of Chlamydia trachomatis genitourinary infections. Ann Intern Med 1988; 108:710-17.